Sjogren's Syndrome And Lupus

Stuart S. Kassan MD FACP, Clinical Professor of Medicine, University of Colorado Health Sciences Center
A reprint from Lupus Foundation of America Article Library 2001


 
Introduction
Sjogren's syndrome is a chronic autoimmune disorder in which the glands that produce tears and saliva do not function correctly.
Description of Sjogren's syndrome
Sjogren's syndrome can occur : Several studies have shown various differences between people with Sjogren's syndrome alone and those with Sjogren's syndrome and another connective tissue disease. Because of these differences :
  1. Sjogren's syndrome is termed   primary Sjogren's syndrome   when it occurs by itself.
  2. When associated with another connective tissue disease, such as SLE or RA, it is termed   secondary Sjogren's syndrome.

The diagnostic criteria for Sjogren's syndrome include : Because the disease is mild in many people, the first signs of mucosal dryness may be present for years before the disease becomes clearly evident.
 
Symptoms of Sjogren's syndrome
Mouth
The symptom most associated with Sjogren's syndrome is oral ( mouth ) dryness, known as xerostomia.
Other oral symptoms that may be present include : Fluid intake is often necessary both with and between meals because of the decrease in salivary gland secretion.
The parotid glands ( major salivary glands located behind the jaw ) may be enlarged and painful swelling may also be noted. Eyes
Eye involvement is the other major manifestation of Sjogren's syndrome.
People often complain of a sandy or gritty feeling in their eyes, especially in the morning.
Other ocular symptoms that may be present include : Glands Extraglandular
Symptoms that show up outside the glands are seen in one-third of people with primary Sjogren's syndrome, but rarely in those with secondary syndrome.
These extraglandular symptoms may include : Such symptoms and signs may be associated with :
  1. lung involvement
  2. kidney involvement
  3. vasculitis ( inflammation of blood vessels ).
  4. lymphomas ( tumors of the lymph glands ), which develop in 6% of people with Sjogren's syndrome who have systemic disease.

Laboratory abnormalities in Sjogren's syndrome
Autoantibodies are common in Sjogren's, with Other nonspecific laboratory abnormalities that are commonly noted in Sjogren's : Certain genes may also be found more frequently in people with primary Sjogren's. These "histocompatibility antigens" may include HLA-B8 and HLA-DR3.
 
Diagnostic tests and procedures in Sjogren's syndrome
Several diagnostic tests are commonly used in people suspected of having Sjogren's syndrome :
  1. In the Schirmer's test, a piece of filter paper is placed in the corner of the eye to measure the degree of wetting after five minutes.
  2. The Rose-Bengal staining test determines whether there is inflammation of the cornea.
  3. Salivary gland flow rates help to determine whether there is decreased saliva production.
  4. Salivary gland biopsy of the lip or parotid gland may help to establish the diagnosis.

Associations of Sjogren's syndrome with lupus and other disorders
The coexistence of Sjogren's syndrome with SLE was first described in 1959. Since that report, numerous studies have compared and contrasted the two diseases. Many of the clinical and serological ( serum-related ) features of Sjogren's syndrome and SLE make the precise diagnosis difficult because there are similarities between the two diseases.
Treatment for Sjogren's syndrome
Treatment for Sjogren's syndrome attempts to relieve the effects of chronic dryness of the mouth and eyes by increasing the lubrication and moisturization of the affected tissues :
  1. Artificial tears in various forms help replace decreased tear production. However, artificial tears containing preservatives may cause irritation.
  2. Plugging the lacrimal ( tear ) ducts with temporary or longer lasting collagen plugs, can be very effective in increasing moisture of the conjunctiva and cornea. Various other experimental agents are being developed.
  3. Local oral agents have been used for continuing lubrication, but with limited success.
  4. Systemic agents have also been used, with varied success, including :
Hydroxychloroquine   ( brand name : Plaquenil ), an antimalarial, has been used for several reasons : Systemic corticosteroids and/or immunosuppressive agents   ( cytotoxic drugs ) have been used for various extraglandular symptoms of Sjogren's syndrome, such as : However, cytotoxic agents should be used with great care as they may increase the risk of lymphoma.
 
Prognosis of Sjogren's syndrome
 
Disclaimer :
The Lupus Group of WA ( Inc ) does not recommend or endorse any products, drugs, treatments, procedures, medical or health professional in this article. We suggest you discuss this information with your doctor or specialist.